Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.11
Delayed Data
As of Mar 24
 -0.04 / -0.96%
Today’s Change
2.63
Today|||52-Week Range
6.30
+13.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues640.0K610.0K610.0K676.0K
 
 
 
 
 
Depreciation And Amortization3.0K3.0K2.0K3.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.5M10.6M9.1M8.7M
 
 
 
 
 
Research And Development6.2M6.6M5.3M4.8M
 
 
 
 
 
Total Operating Expenses10.5M10.6M9.1M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-10.0M-8.5M-8.1M
 
 
 
 
 
Interest Expense On Debt298.0K476.0K473.0K474.0K
 
 
 
 
 
Other Expenses76.0K23.0K49.0K10.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.1M-10.4M-9.0M-8.5M
 
 
 
 
 
Net Income-10.1M-10.4M-9.0M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.4M14.5M14.5M19.3M
 
 
 
 
 
Shares To Calculate EPS Diluted14.4M14.5M14.5M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.72-$0.72-$0.62-$0.44
 
 
 
 
 
EPS Diluted-$0.72-$0.72-$0.62-$0.44